|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
15,080,000 |
Market
Cap: |
25.18(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.42 - $2.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
29,258 |
Total Buy Value |
$0 |
$0 |
$0 |
$67,776 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
476 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Krogulski Kenneth |
Director |
|
2022-05-19 |
4 |
AB |
$2.29 |
$261 |
D/D |
114 |
186,741 |
|
9% |
|
Galante Joseph C |
Director |
|
2022-05-18 |
4 |
AB |
$2.31 |
$157 |
D/D |
68 |
46,551 |
|
1% |
|
Jones James |
Director |
|
2022-05-18 |
4 |
AB |
$2.31 |
$79 |
D/D |
34 |
21,105 |
|
1% |
|
Young Caroline |
Director |
|
2022-05-18 |
4 |
AB |
$2.31 |
$53 |
D/D |
23 |
16,275 |
|
1% |
|
Krogulski Kenneth |
Director |
|
2022-05-18 |
4 |
AB |
$2.31 |
$263 |
D/D |
114 |
186,627 |
|
1% |
|
Galante Joseph C |
Director |
|
2022-05-17 |
4 |
AB |
$2.35 |
$160 |
D/D |
68 |
46,483 |
|
6% |
|
Jones James |
Director |
|
2022-05-17 |
4 |
AB |
$2.35 |
$80 |
D/D |
34 |
21,071 |
|
6% |
|
Young Caroline |
Director |
|
2022-05-17 |
4 |
AB |
$2.35 |
$54 |
D/D |
23 |
16,252 |
|
6% |
|
Krogulski Kenneth |
Director |
|
2022-05-17 |
4 |
AB |
$2.35 |
$268 |
D/D |
114 |
186,513 |
|
6% |
|
Galante Joseph C |
Director |
|
2022-05-16 |
4 |
AB |
$2.31 |
$157 |
D/D |
68 |
46,415 |
|
7% |
|
Jones James |
Director |
|
2022-05-16 |
4 |
AB |
$2.31 |
$79 |
D/D |
34 |
21,037 |
|
7% |
|
Young Caroline |
Director |
|
2022-05-16 |
4 |
AB |
$2.31 |
$53 |
D/D |
23 |
15,229 |
|
7% |
|
Krogulski Kenneth |
Director |
|
2022-05-16 |
4 |
AB |
$2.31 |
$263 |
D/D |
114 |
186,399 |
|
7% |
|
Galante Joseph C |
Director |
|
2022-05-13 |
4 |
AB |
$2.32 |
$158 |
D/D |
68 |
46,347 |
|
16% |
|
Jones James |
Director |
|
2022-05-13 |
4 |
AB |
$2.32 |
$79 |
D/D |
34 |
21,003 |
|
16% |
|
Young Caroline |
Director |
|
2022-05-13 |
4 |
AB |
$2.32 |
$53 |
D/D |
23 |
16,206 |
|
16% |
|
Krogulski Kenneth |
Director |
|
2022-05-13 |
4 |
AB |
$2.32 |
$264 |
D/D |
114 |
186,285 |
|
16% |
|
Galante Joseph C |
Director |
|
2022-05-12 |
4 |
AB |
$2.23 |
$152 |
D/D |
68 |
46,279 |
|
16% |
|
Jones James |
Director |
|
2022-05-12 |
4 |
AB |
$2.23 |
$76 |
D/D |
34 |
20,969 |
|
16% |
|
Young Caroline |
Director |
|
2022-05-12 |
4 |
AB |
$2.23 |
$51 |
D/D |
23 |
16,183 |
|
16% |
|
Krogulski Kenneth |
Director |
|
2022-05-12 |
4 |
AB |
$2.23 |
$254 |
D/D |
114 |
186,171 |
|
16% |
|
Galante Joseph C |
Director |
|
2022-05-11 |
4 |
AB |
$2.37 |
$161 |
D/D |
68 |
46,211 |
|
16% |
|
Jones James |
Director |
|
2022-05-11 |
4 |
AB |
$2.37 |
$81 |
D/D |
34 |
20,935 |
|
16% |
|
Young Caroline |
Director |
|
2022-05-11 |
4 |
AB |
$2.37 |
$55 |
D/D |
23 |
16,160 |
|
16% |
|
Krogulski Kenneth |
Director |
|
2022-05-11 |
4 |
AB |
$2.37 |
$270 |
D/D |
114 |
186,057 |
|
16% |
|
1400 Records found
|
|
Page 19 of 56 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|